Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...

Roth Capital issued their Q1 2026 EPS estimates for shares of Aurora Cannabis in a report released on Thursday, February 6th.

From political maneuvering in Washington to major corporate developments across the global cannabis landscape, this week has ...

Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also ...

It was a big day for Canadian cannabis stock Aurora Cannabis (TSE:ACB), as it posted its earnings report with a hefty ...

Aurora Cannabis Inc (ACB) reports a robust quarter with significant increases in global medical cannabis revenue and a ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

Aurora Cannabis (ACB) announces a strategic supply agreement with SNDL Inc, (SNDL) a Canadian licensed producer and ...

Aurora Cannabis (ACB) stock surges 27% in premarket after reporting strong Q3 fiscal 2025 results with record-breaking ...

CA$31.6m (up from CA$24.2m loss in 3Q 2024). Profit margin: 36% (up from net loss in 3Q 2024). EPS: CA$0.57 (up from CA$0.51 ...

Cannabis stocks Tilray (TLRY) and Canopy Growth (CGC) rallied 7% and 22.2%, respectively, on Wednesday. One of the key drivers of this upside ...

Analysts at Roth Capital issued their Q1 2026 earnings per share estimates for shares of Aurora Cannabis in a research report issued on Thursday, February 6th. Roth Capital analyst W. Kirk expects ...